Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study (Q43299909)
Jump to navigation
Jump to search
scientific article published in June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study |
scientific article published in June 2009 |
Statements
1 reference
Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study (English)
1 reference
Kjeld Schmiegelow
1 reference
Mats Heyman
1 reference
Jon Kristinsson
1 reference
Ulla B Mogensen
1 reference
Susanne Rosthøj
1 reference
Kim Vettenranta
1 reference
Finn Wesenberg
1 reference
Ulla Saarinen-Pihkala
1 reference
Nordic Society of Paediatric Haematology and Oncology (NOPHO)
1 reference
1 June 2009
1 reference
1 reference
Identifiers
1 reference